Quantcast
Last updated on April 18, 2014 at 17:22 EDT

3rd annual Walk to Fight Arthritis a resounding success

June 11, 2012

~ Thousands walked to help find a cure for one of Canada’s leading
causes of disability ~

TORONTO, June 11, 2012 /CNW/ – The 3(rd) annual Walk to Fight Arthritis presented by the makers of TYLENOL®, held on Sunday, June 10(th) in 21 communities across Canada, was hailed as a resounding success by all who attended.  In total,
almost $1.6 million was raised, bringing the total raised over the
course of 3 years of the Walk to almost $3.9 million.  In total, 8,000
participants took part in this year’s Walk.

“It was truly touching to see the overwhelming support of those gathered
to participate in the Walk to Fight Arthritis,” says Janet Yale,
President and CEO of The Arthritis Society.  “Every dollar earned and
every step we take brings us closer to finding a cure. We are most
grateful for our sponsors, participants, volunteers and employees who
took time to generously support the millions of Canadians living with
arthritis.”

The success of the Walk, this year and in the future, allows the Society
to increase awareness of arthritis, fund much needed research and
programs to support Canadians living with the disease.

Pat Smallcombe, Managing Director, Johnson & Johnson Inc. participated
in the Toronto Walk to Fight Arthritis along with many other Johnson &
Johnson Inc.  employees who represented  presenting sponsor, TYLENOL®. “I’d like to thank The Arthritis Society for the work they do for the
4.6 million Canadians living with arthritis,” says Smallcombe. “TYLENOL® is very proud to be presenting sponsor for such an outstanding event. 
Our hope is that through our partnership with The Society we are making
a difference in the lives of those living with this debilitating
disease. ”

For more information and to see photos from the event, visit www.WalkToFightArthritis.ca and check out the Walk on Facebook at www.facebook.com/WalkToFightArthritis.

About The Arthritis Society

The Arthritis Society is dedicated to a vision of Living well while creating a future without arthritis. It is Canada’s principal health charity providing education, programs
and support to 4.6 million Canadians with arthritis and their loved
ones. Since its founding in 1948, The Society has been the largest
non-government funder of arthritis research in Canada by investing more
than $175 million in projects that have led to breakthroughs in the
diagnosis, treatment and care of people with arthritis.

For more information, visit www.arthritis.ca

About McNeil Consumer
Healthcare                                                                                                      

McNeil Consumer Healthcare markets a broad range of well-known and
trusted over-the-counter (OTC) products around the globe. In Canada,
McNeil Consumer Healthcare, division of Johnson & Johnson Inc., markets
products in the adult and pediatric pain relief, allergy,
gastro-intestinal and nicotine-replacement categories under the brand
names TYLENOL®, MOTRIN®, BENYLIN®, BENADRYL®, REACTINE®, PEPCID®,
IMODIUM®, ROLAIDS®, NICORETTE® and NICODERM®. For more information
visit, www.jnjcanada.com

SOURCE Arthritis Society

Image with caption: “3rd annual Walk to Fight Arthritis a resounding success (CNW Group/Arthritis Society)”. Image available at: http://photos.newswire.ca/images/download/20120611_C7450_PHOTO_EN_14971.jpg


Source: PR Newswire